BAYRY News and Press, Bayer AG ADR From 07/12/22

We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by managers who think and act as owne...

Bayer ( OTCPK:BAYRY ) and BASF ( OTCQX:BASFY ) won a new trial on a $60M damage award they had been ordered to pay a Missouri farmer who said the dicamba herbicide drifted onto his peach orchard and harmed his crops, Reuters reported on Thursday. The 8th U.S. Circuit Court o...

Bayer AG is one of the world’s largest “life-science” conglomerates. For a global company with such a strong global presence and portfolio of valuable intellectual property, Bayer stock is trading ridiculously cheap. Judged by a historical 2-year average indus...

Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analy...

China's National Medical Products Administration (NMPA) approved Bayer's ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) Kerendia (finerenone) to treat chronic kidney disease (CKD) associated with type 2 diabetes (T2D) in adults, to reduce the risk of sustained eGFR decline and ...

Genetic medicines company ReCode Therapeutics has got $120M in an extended financing round led by new investors including an investment unit of Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ). AyurMaya, an affiliate of investment firm Matrix Capital Management, co-led the round, whi...

The U.S. Supreme Court on Monday let stand an $87M award against Bayer (OTCPK:BAYRY), again rejecting the company as it tries to fend off lawsuits alleging its Roundup weedkiller causes cancer. In making no comment, the justices left in place a jury's finding in favor of two defendants in a C...

Bayer Runs Out of Appeals at US Supreme Court as Thousands of Cancer Lawsuits Await over Roundup Herbicide PR Newswire Fears Nachawati trial lawyers gearing up for next Roundup cancer trial in August WASHINGTON , June 22, 2022 /PRNewswire/ -- Baye...

Harris Associates’ 13F portfolio value increased from $64.23B to $75.90B this quarter. They increased Charter Communications, General Motors, Amazon.com, and Netflix while reducing Humana, Hilton Worldwide, and General Dynamics. The top three positions are Alphabet, Fiserv,...

Exelixis (NASDAQ:EXEL) said it began a phase 3 trial of XL092 in combination with Roche's (OTCQX:RHHBY) (OTCQX:RHHBF) Tecentriq (atezolizumab) versus Bayer's (OTCPK:BAYRY) (OTCPK:BAYZF) Stivarga (regorafenib) in patients with metastatic colorectal cancer which is not microsatellite insta...